1. Pre-Exposure Prophylaxis to Prevent HIV Infection: Current Status, Future Opportunities and Challenges

   • Douglas S. Krakower
   • Kenneth H. Mayer

   Current Opinion 12 February 2015 Pages: 243 - 251

2. Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

   • George G. Zhanel
   • Riley Love
   • James A. Karlowsky

   Review Article 12 February 2015 Pages: 253 - 270

   

3. Pemphigus Vulgaris: An Evidence-Based Treatment Update

   • Cathy Y. Zhao
   • Dedee F. Murrell

   Systematic Review 06 February 2015 Pages: 271 - 284

   

4. Obinutuzumab: A Review of Its Use in Patients with Chronic Lymphocytic Leukaemia

   • Sheridan M. Hoy

   Adis Drug Evaluation 14 January 2015 Pages: 285 - 296

   

5. Ruxolitinib: A Review of Its Use in Patients with Myelofibrosis

   • Greg L. Plosker

   Adis Drug Evaluation 20 January 2015 Pages: 297 - 308

6. Tacrolimus Prolonged Release (Envarsus^®): A Review of Its Use in Kidney and Liver Transplant Recipients

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 23 January 2015 Pages: 309 - 320

   

7. Blinatumomab: First Global Approval

   • Mark Sanford

   R&D Insight Report 31 January 2015 Pages: 321 - 327

8. Secukinumab: First Global Approval

   • Mark Sanford
   • Kate McKeage

   R&D Insight Report 04 February 2015 Pages: 329 - 338